High dose of intrathecal netilmicin in the treatment of nosocomial Acinetobacter baumannii meningitis.
Buke
Cagri
C
Sipahi
Oguz Resat
OR
Yurtseven
Taskin
T
Zileli
Mehmet
M
D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000209:etiology; D040981:Acinetobacter baumannii / Q000302:isolation & purification*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002543:Cerebral Hemorrhage / Q000601:surgery; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003399:Craniotomy / Q000009:adverse effects; D003428:Cross Infection; D004305:Dose-Response Relationship, Drug; D024901:Drug Resistance, Multiple, Bacterial; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology / Q000601:surgery; D007278:Injections, Spinal; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000209:etiology; D009428:Netilmicin / Q000008:administration & dosage*; D017287:Ventriculoperitoneal Shunt
D000900:Anti-Bacterial Agents; D009428:Netilmicin